Preventing IV Failures: How ivWatch is Saving Lives with Real-Time Alerts
IV failures from infiltration and extravasation can cause serious complications, including drug delivery errors and even life-threatening situations. In this episode, Gary Warren, CEO of ivWatch, explains how their cutting-edge technology is changing the game for IV therapy. With nearly 70 patents and FDA clearance, ivWatch uses near-infrared light and advanced algorithms to catch IV leaks early. Gary also shares insights into scaling the company, global healthcare challenges, and the supportive business climate in Virginia. Discover how ivWatch is improving patient safety, saving lives, and tackling critical healthcare issues worldwide.
Key Points
- Developing a world-class business requires adaptability and a commitment to constant improvement, as exemplified by Gary Warren's journey with IV Watch.
- The healthcare industry is slow to adopt new technologies due to inherent skepticism and a preference for proven solutions, which adds complexity to the sales cycle for medical innovations.
- Building a strong team and fostering a supportive work environment are crucial for sustaining business growth and achieving long-term success, especially in highly regulated and capital-intensive fields.
Chapters
0:00 | |
4:23 | |
7:24 | |
12:06 | |
17:21 | |
22:07 | |
25:34 | |
29:10 | |
34:44 | |
40:19 | |
44:31 | |
49:35 | |
52:04 | |
56:42 | |
59:23 |
Transcript
Loading transcript...
- / -